English

MAXIM PHARMACEUTICALS INC

EDGAR

Annual report (10-K) · filed 2005-12-14

46 filing records in this dataset, filed from 1996-08-23 to 2005-12-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 7.56 million USD 2005-09-30 Source
Exact value

7560000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-27.7 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Net income: -9587000 USD · 2004-10-01 – 2004-12-31 Source
Net income: -18810000 USD · 2004-10-01 – 2005-03-31 Source
Net income: -9587000 USD · 2004-10-01 – 2004-12-31 Source
Net income: -21758000 USD · 2004-10-01 – 2005-06-30 Source
Net income: -18810000 USD · 2004-10-01 – 2005-03-31 Source
Net income: -27693000 USD · 2004-10-01 – 2005-09-30 Source
Net income: -21758000 USD · 2004-10-01 – 2005-06-30 Source

Operating cash flow

-27.6 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Operating cash flow: -11649000 USD · 2004-10-01 – 2004-12-31 Source
Operating cash flow: -19708000 USD · 2004-10-01 – 2005-03-31 Source
Operating cash flow: -11649000 USD · 2004-10-01 – 2004-12-31 Source
Operating cash flow: -24195000 USD · 2004-10-01 – 2005-06-30 Source
Operating cash flow: -19708000 USD · 2004-10-01 – 2005-03-31 Source
Operating cash flow: -27620000 USD · 2004-10-01 – 2005-09-30 Source
Operating cash flow: -24195000 USD · 2004-10-01 – 2005-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-12-14.

Financial data available through: 2005-09-30.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 5 of 11 periods available· newest 2005-09-30
Net income: 11 of 11 periods available· newest 2005-09-30
Operating cash flow: 11 of 11 periods available· newest 2005-09-30
Capital expenditure: 11 of 11 periods available· newest 2005-09-30
Total assets: 11 of 11 periods available· newest 2005-09-30
Total liabilities: 1 of 11 periods available· newest 1995-09-30
Current assets: 11 of 11 periods available· newest 2005-09-30
Current liabilities: 11 of 11 periods available· newest 2005-09-30
Cash and cash equivalents: 11 of 11 periods available· newest 2005-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 17.28 million

Prior period

−USD 44.97 million

2003-10-01 – 2004-09-30
Current period

−USD 27.69 million

2004-10-01 – 2005-09-30

Exact inputs and evidence

-27693000 − -44968000 = 17275000 USD

-44968000 USD · 2003-10-01 – 2004-09-30
Inspect prior input Prior source
-27693000 USD · 2004-10-01 – 2005-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Year-over-year change in Net income: 17275000 USD Concept: fundies:NetIncome Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -27693000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#18666 Input fundies:NetIncome: -44968000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#18666
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 13.11 million

Prior period

−USD 40.73 million

2003-10-01 – 2004-09-30
Current period

−USD 27.62 million

2004-10-01 – 2005-09-30

Exact inputs and evidence

-27620000 − -40730000 = 13110000 USD

-40730000 USD · 2003-10-01 – 2004-09-30
Inspect prior input Prior source
-27620000 USD · 2004-10-01 – 2005-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Year-over-year change in Operating cash flow: 13110000 USD Concept: fundies:OperatingCashFlow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -27620000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 Input fundies:OperatingCashFlow: -40730000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-83.5%

Prior period

USD 672,000

2003-10-01 – 2004-09-30
Current period

USD 111,000

2004-10-01 – 2005-09-30

Exact inputs and evidence

111000 − 672000 = -561000 USD

672000 USD · 2003-10-01 – 2004-09-30
Inspect prior input Prior source
111000 USD · 2004-10-01 – 2005-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Year-over-year change in Capital expenditure: -561000 USD Concept: fundies:CapitalExpenditure Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 111000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 Input fundies:CapitalExpenditure: 672000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1995-10-01 – 1996-09-30	−USD 833,488 Exact value Exact value: -833488 USD 1995-10-01 – 1996-09-30: -833488 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 1996-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -833488 USD Concept: fundies:NetIncome Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:NetIncome: -833488 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5066 The citation records this snapshot. The page link may show a newer release later.	−USD 2.69 million Exact value Exact value: -2685394 USD 1995-10-01 – 1996-09-30: -2685394 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 1996-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -2685394 USD Concept: fundies:OperatingCashFlow Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2685394 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 The citation records this snapshot. The page link may show a newer release later.	USD 23,524 Exact value Exact value: 23524 USD 1995-10-01 – 1996-09-30: 23524 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 1996-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 23524 USD Concept: fundies:CapitalExpenditure Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23524 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.	−USD 2.71 million Calculation and evidence -2685394 − 23524 USD Exact free cash flow: -2708918 USD 1995-10-01 – 1996-09-30: -2685394 USD · Inspect Operating Cash Flow · Source 1995-10-01 – 1996-09-30: 23524 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 1996-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -2708918 USD Concept: free-cash-flow Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2685394 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 Input fundies:CapitalExpenditure: 23524 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.
1997 1996-10-01 – 1997-09-30	−USD 6.9 million Exact value Exact value: -6895149 USD 1996-10-01 – 1997-09-30: -6895149 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 1997-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -6895149 USD Concept: fundies:NetIncome Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:NetIncome: -6895149 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5066 The citation records this snapshot. The page link may show a newer release later.	−USD 5.91 million Exact value Exact value: -5909719 USD 1996-10-01 – 1997-09-30: -5909719 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 1997-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -5909719 USD Concept: fundies:OperatingCashFlow Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5909719 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 The citation records this snapshot. The page link may show a newer release later.	USD 804,454 Exact value Exact value: 804454 USD 1996-10-01 – 1997-09-30: 804454 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 1997-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 804454 USD Concept: fundies:CapitalExpenditure Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 804454 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.	−USD 6.71 million Calculation and evidence -5909719 − 804454 USD Exact free cash flow: -6714173 USD 1996-10-01 – 1997-09-30: -5909719 USD · Inspect Operating Cash Flow · Source 1996-10-01 – 1997-09-30: 804454 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 1997-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -6714173 USD Concept: free-cash-flow Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5909719 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 Input fundies:CapitalExpenditure: 804454 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.
1998 1997-10-01 – 1998-09-30	−USD 21.85 million Exact value Exact value: -21854572 USD 1997-10-01 – 1998-09-30: -21854572 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 1998-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -21854572 USD Concept: fundies:NetIncome Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:NetIncome: -21854572 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5066 The citation records this snapshot. The page link may show a newer release later.	−USD 14.76 million Exact value Exact value: -14763106 USD 1997-10-01 – 1998-09-30: -14763106 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 1998-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -14763106 USD Concept: fundies:OperatingCashFlow Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14763106 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Exact value Exact value: 1098586 USD 1997-10-01 – 1998-09-30: 1098586 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 1998-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 1098586 USD Concept: fundies:CapitalExpenditure Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1098586 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.	−USD 15.86 million Calculation and evidence -14763106 − 1098586 USD Exact free cash flow: -15861692 USD 1997-10-01 – 1998-09-30: -14763106 USD · Inspect Operating Cash Flow · Source 1997-10-01 – 1998-09-30: 1098586 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 1998-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -15861692 USD Concept: free-cash-flow Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14763106 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5088 Input fundies:CapitalExpenditure: 1098586 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001047469-99-002575.txt#5094 The citation records this snapshot. The page link may show a newer release later.
1999 1998-10-01 – 1999-09-30	−USD 39.23 million Exact value Exact value: -39226350 USD 1998-10-01 – 1999-09-30: -39226350 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 1999-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -39226350 USD Concept: fundies:NetIncome Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:NetIncome: -39226350 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6434 The citation records this snapshot. The page link may show a newer release later.	−USD 36.03 million Exact value Exact value: -36032159 USD 1998-10-01 – 1999-09-30: -36032159 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 1999-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -36032159 USD Concept: fundies:OperatingCashFlow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36032159 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6461 The citation records this snapshot. The page link may show a newer release later.	USD 252,560 Exact value Exact value: 252560 USD 1998-10-01 – 1999-09-30: 252560 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 1999-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 252560 USD Concept: fundies:CapitalExpenditure Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 252560 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6466 The citation records this snapshot. The page link may show a newer release later.	−USD 36.28 million Calculation and evidence -36032159 − 252560 USD Exact free cash flow: -36284719 USD 1998-10-01 – 1999-09-30: -36032159 USD · Inspect Operating Cash Flow · Source 1998-10-01 – 1999-09-30: 252560 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 1999-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -36284719 USD Concept: free-cash-flow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36032159 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6461 Input fundies:CapitalExpenditure: 252560 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6466 The citation records this snapshot. The page link may show a newer release later.
2000 1999-10-01 – 2000-09-30	−USD 77.49 million Exact value Exact value: -77489046 USD 1999-10-01 – 2000-09-30: -77489046 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2000-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -77489046 USD Concept: fundies:NetIncome Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:NetIncome: -77489046 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6434 The citation records this snapshot. The page link may show a newer release later.	−USD 36.86 million Exact value Exact value: -36860675 USD 1999-10-01 – 2000-09-30: -36860675 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2000-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -36860675 USD Concept: fundies:OperatingCashFlow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36860675 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6461 The citation records this snapshot. The page link may show a newer release later.	USD 1.58 million Exact value Exact value: 1577963 USD 1999-10-01 – 2000-09-30: 1577963 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2000-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 1577963 USD Concept: fundies:CapitalExpenditure Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1577963 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6466 The citation records this snapshot. The page link may show a newer release later.	−USD 38.44 million Calculation and evidence -36860675 − 1577963 USD Exact free cash flow: -38438638 USD 1999-10-01 – 2000-09-30: -36860675 USD · Inspect Operating Cash Flow · Source 1999-10-01 – 2000-09-30: 1577963 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2000-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -38438638 USD Concept: free-cash-flow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36860675 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6461 Input fundies:CapitalExpenditure: 1577963 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0000912057-01-544496.txt#6466 The citation records this snapshot. The page link may show a newer release later.
2001 2000-10-01 – 2001-09-30	−USD 37.32 million Exact value Exact value: -37323000 USD 2000-10-01 – 2001-09-30: -37323000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2001-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -37323000 USD Concept: fundies:NetIncome Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:NetIncome: -37323000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-03-028979.txt#26576 The citation records this snapshot. The page link may show a newer release later.	−USD 38.88 million Exact value Exact value: -38877000 USD 2000-10-01 – 2001-09-30: -38877000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2001-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -38877000 USD Concept: fundies:OperatingCashFlow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38877000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-03-028979.txt#27239 The citation records this snapshot. The page link may show a newer release later.	USD 3.92 million Exact value Exact value: 3918000 USD 2000-10-01 – 2001-09-30: 3918000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2001-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 3918000 USD Concept: fundies:CapitalExpenditure Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3918000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-03-028979.txt#27403 The citation records this snapshot. The page link may show a newer release later.	−USD 42.8 million Calculation and evidence -38877000 − 3918000 USD Exact free cash flow: -42795000 USD 2000-10-01 – 2001-09-30: -38877000 USD · Inspect Operating Cash Flow · Source 2000-10-01 – 2001-09-30: 3918000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2001-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -42795000 USD Concept: free-cash-flow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38877000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-03-028979.txt#27239 Input fundies:CapitalExpenditure: 3918000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-03-028979.txt#27403 The citation records this snapshot. The page link may show a newer release later.
2002 2001-10-01 – 2002-09-30	−USD 64.32 million Exact value Exact value: -64323000 USD 2001-10-01 – 2002-09-30: -64323000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2002-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -64323000 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -64323000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-04-039317.txt#22636 The citation records this snapshot. The page link may show a newer release later.	−USD 32.38 million Exact value Exact value: -32383000 USD 2001-10-01 – 2002-09-30: -32383000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2002-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -32383000 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32383000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-04-039317.txt#23304 The citation records this snapshot. The page link may show a newer release later.	USD 1.59 million Exact value Exact value: 1590000 USD 2001-10-01 – 2002-09-30: 1590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2002-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 1590000 USD Concept: fundies:CapitalExpenditure Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1590000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-04-039317.txt#23468 The citation records this snapshot. The page link may show a newer release later.	−USD 33.97 million Calculation and evidence -32383000 − 1590000 USD Exact free cash flow: -33973000 USD 2001-10-01 – 2002-09-30: -32383000 USD · Inspect Operating Cash Flow · Source 2001-10-01 – 2002-09-30: 1590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2002-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -33973000 USD Concept: free-cash-flow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32383000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-04-039317.txt#23304 Input fundies:CapitalExpenditure: 1590000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-04-039317.txt#23468 The citation records this snapshot. The page link may show a newer release later.
2003 2002-10-01 – 2003-09-30	−USD 45.46 million Exact value Exact value: -45456000 USD 2002-10-01 – 2003-09-30: -45456000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2003-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -45456000 USD Concept: fundies:NetIncome Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:NetIncome: -45456000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#18666 The citation records this snapshot. The page link may show a newer release later.	−USD 37.46 million Exact value Exact value: -37461000 USD 2002-10-01 – 2003-09-30: -37461000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2003-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -37461000 USD Concept: fundies:OperatingCashFlow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37461000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 The citation records this snapshot. The page link may show a newer release later.	USD 842,000 Exact value Exact value: 842000 USD 2002-10-01 – 2003-09-30: 842000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2003-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 842000 USD Concept: fundies:CapitalExpenditure Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 842000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.	−USD 38.3 million Calculation and evidence -37461000 − 842000 USD Exact free cash flow: -38303000 USD 2002-10-01 – 2003-09-30: -37461000 USD · Inspect Operating Cash Flow · Source 2002-10-01 – 2003-09-30: 842000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2003-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -38303000 USD Concept: free-cash-flow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37461000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 Input fundies:CapitalExpenditure: 842000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.
2004 2003-10-01 – 2004-09-30	−USD 44.97 million Exact value Exact value: -44968000 USD 2003-10-01 – 2004-09-30: -44968000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2004-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -44968000 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:NetIncome: -44968000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#18666 The citation records this snapshot. The page link may show a newer release later.	−USD 40.73 million Exact value Exact value: -40730000 USD 2003-10-01 – 2004-09-30: -40730000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2004-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -40730000 USD Concept: fundies:OperatingCashFlow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40730000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 The citation records this snapshot. The page link may show a newer release later.	USD 672,000 Exact value Exact value: 672000 USD 2003-10-01 – 2004-09-30: 672000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2004-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 672000 USD Concept: fundies:CapitalExpenditure Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 672000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.	−USD 41.4 million Calculation and evidence -40730000 − 672000 USD Exact free cash flow: -41402000 USD 2003-10-01 – 2004-09-30: -40730000 USD · Inspect Operating Cash Flow · Source 2003-10-01 – 2004-09-30: 672000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2004-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -41402000 USD Concept: free-cash-flow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40730000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 Input fundies:CapitalExpenditure: 672000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.
2005 2004-10-01 – 2005-09-30	−USD 27.69 million Exact value Exact value: -27693000 USD 2004-10-01 – 2005-09-30: -27693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Net Income: -27693000 USD Concept: fundies:NetIncome Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ANetIncome&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:NetIncome: -27693000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#18666 The citation records this snapshot. The page link may show a newer release later.	−USD 27.62 million Exact value Exact value: -27620000 USD 2004-10-01 – 2005-09-30: -27620000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Operating Cash Flow: -27620000 USD Concept: fundies:OperatingCashFlow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3AOperatingCashFlow&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27620000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 The citation records this snapshot. The page link may show a newer release later.	USD 111,000 Exact value Exact value: 111000 USD 2004-10-01 – 2005-09-30: 111000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Capital Expenditure: 111000 USD Concept: fundies:CapitalExpenditure Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351/explain?concept=fundies%3ACapitalExpenditure&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 111000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.	−USD 27.73 million Calculation and evidence -27620000 − 111000 USD Exact free cash flow: -27731000 USD 2004-10-01 – 2005-09-30: -27620000 USD · Inspect Operating Cash Flow · Source 2004-10-01 – 2005-09-30: 111000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MAXIM PHARMACEUTICALS INC · 2005-09-30 MAXIM PHARMACEUTICALS INC (edgar:1013351) Free cash flow: -27731000 USD Concept: free-cash-flow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T08:18:54Z Snapshot: a398f39c5130081a2a4897387dca7dee7c01b8bb3ed984fb1d92d9038deda6c9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013351?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27620000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19370 Input fundies:CapitalExpenditure: 111000 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013351/0001104659-05-060826.txt#19533 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

46 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001013351, 1013351, edgar:1013351

MAXIM PHARMACEUTICALS INC

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation